BioMarin Pharmaceutical Inc

12 jun 2026, 23:41 UTC

Biomarin Pharmaceutical shares traded lower in after-market hours, reflecting broader market dynamics amid rising bond yields and mixed equity performance.

11 jun 2026, 19:16 UTC

Biomarin Pharmaceutical Inc shares are lower today, reaching an early session low. Broader economic news includes an unexpected rise in initial jobless claims.

10 jun 2026, 20:03 UTC

Biomarin Pharmaceutical shares are lower today, reflecting broader market trends amid volatility. The stock peaked earlier in the session before declining significantly.

9 jun 2026, 20:03 UTC

Biomarin Pharmaceutical Inc shares are higher, reaching a session high and trading above its 20-day moving average. No specific news was identified for the move.

8 jun 2026, 22:51 UTC

Biomarin Pharmaceutical shares are lower in after-market trading, reflecting a notable decline despite a broader rebound in US stocks, particularly in the semiconductor sector.

5 jun 2026, 20:07 UTC

Biomarin Pharmaceutical Inc shares are modestly higher, reflecting broader market gains amid robust job growth data. No specific company news was identified.

4 jun 2026, 22:31 UTC

Biomarin Pharmaceutical Inc is trading lower in after-market hours amid a broader market decline and rising U.S. Treasury yields impacting biotechnology stocks.

3 jun 2026, 20:06 UTC

Biomarin Pharmaceutical shares are higher amid broader market strength following a positive ADP Employment Report, which showed job growth exceeding expectations.

2 jun 2026, 20:02 UTC

Biomarin Pharmaceutical Inc shares are lower today, continuing a decline since Monday. The stock closed at its lowest point after an early high.

1 jun 2026, 23:03 UTC

Biomarin Pharmaceutical shares declined in after-market trading, continuing a downward trend since Monday's close, despite remaining above the 20-day moving average.

29 mei 2026, 23:41 UTC

Biomarin Pharmaceutical Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid routine trading patterns.

28 mei 2026, 22:36 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market trading, reflecting notable movement since Thursday's close amid broader market dynamics and economic data.

27 mei 2026, 19:41 UTC

Biomarin Pharmaceutical Inc shares are lower Wednesday, reversing recent gains. No specific news was identified to explain the decline since Tuesday's close.

26 mei 2026, 20:02 UTC

Biomarin Pharmaceutical Inc shares are lower today, diverging from a recent trend of higher closes amid rising bond yields and no specific company news.

22 mei 2026, 19:46 UTC

Biomarin Pharmaceutical Inc shares are lower despite positive Phase 3 trial results for Voxzogo, which showed significant growth benefits in children with hypochondroplasia.

21 mei 2026, 23:56 UTC

Biomarin Pharmaceutical Inc shares are lower in after-market trading despite positive Phase 3 trial results for Voxzogo, indicating potential revenue growth opportunities.

20 mei 2026, 23:01 UTC

BioMarin Pharmaceutical shares rise after positive Phase 3 CANOPY-HCH-3 study results for VOXZOGO, showing significant growth in children with hypochondroplasia.

19 mei 2026, 23:01 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours, reflecting a slight gain since Tuesday's close. No specific news was identified for this movement.

18 mei 2026, 23:41 UTC

Citi initiated coverage of Biomarin Pharmaceutical with a Buy rating and $75 price target, contributing to shares' rise in after-market hours.

15 mei 2026, 23:02 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours, rising from a low to a high. No specific company news was identified to explain the movement.

13 mei 2026, 19:26 UTC

Biomarin Pharmaceutical receives a price target upgrade from Evercore ISI to $120, driven by positive research on VOXZOGO® for children with achondroplasia.

12 mei 2026, 20:07 UTC

Biomarin Pharmaceutical's stock rises amid positive healthcare sector sentiment. However, it remains below its 20-day moving average, indicating market caution.

11 mei 2026, 20:02 UTC

Biomarin reports strong Q1 2026 earnings, but shares decline. The anticipated Amicus acquisition and updated revenue guidance fail to boost investor confidence today.

8 mei 2026, 22:01 UTC

Biomarin Pharmaceutical Inc. sees notable after-hours gains. The stock approaches the upper end of its one-month trading range, indicating strong performance.

7 mei 2026, 19:21 UTC

Biomarin shares decline amid broader biotech sector downturn. Analysts remain optimistic about VOXZOGO® expansion, but this hasn't boosted today's price action.

6 mei 2026, 21:01 UTC

Biomarin Pharmaceutical Inc. trades lower after hours. No specific company news was identified, despite positive labor market data boosting overall market sentiment.

5 mei 2026, 20:02 UTC

BioMarin's Q1 2026 results show adjusted EPS of $0.76, missing estimates. Revenue exceeded expectations, but lowered FY2026 EPS guidance weighs on shares today.

4 mei 2026, 23:11 UTC

Biomarin Pharmaceutical reports Q1 2026 results; revenue beats estimates. Adjusted EPS guidance lowered, leading to significant selling pressure in after-hours trading.

30 apr 2026, 15:26 UTC

Biomarin Pharmaceutical rises today, driven by healthcare sector gains. Despite ongoing inflationary pressures, the stock maintains positive momentum since Wednesday's close.